[{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eb6/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eb6/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eb5/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eb5/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eb4/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eb4/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eb3/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eb3/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eb2/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eb2/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eb1/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eb1/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eb0/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eb0/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eaf/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eaf/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eae/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eae/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0ead/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0ead/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eac/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eac/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eab/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eab/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0eaa/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0eaa/a2m-tetramer.png"},{"image":"https://icons.biorender.com/w75xh75/5dded370d8d7a100044a0ea9/a2m-tetramer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded370d8d7a100044a0ea9/a2m-tetramer.png"}]